2024-03-29T05:38:58Z
https://niigata-u.repo.nii.ac.jp/oai
oai:niigata-u.repo.nii.ac.jp:00021731
2022-12-15T03:52:12Z
453:456
471:537:538:1191
3) HBs抗原精密検査による輸血後B型肝炎防止の試み(シンポジウム 輸血をめぐる諸問題 : とくに輸血後肝炎防止について, 第456回新潟医学会)
3) HBs抗原精密検査による輸血後B型肝炎防止の試み(シンポジウム 輸血をめぐる諸問題 : とくに輸血後肝炎防止について, 第456回新潟医学会)
Prevention of Post Transfusion Hepatitis Employing Sensitive Assay for Hepatitis B Surface Antigen Screening(Topics in Transfusion Medicine 1990 : Autologous Transfusion and Post-Transfusion Hepatitis)
小島, 秀男
大竹, 幸子
富樫, 和枝
石口, 重子
山田, 恵子
品田, 章二
post transfusion hepatitis
HBV
HCV
輸血後肝炎
B型肝炎ウイルス
C型肝炎ウイルス
Post transfusion Hepatitis (PTH) is one of serious side effects and some times lead to fulminant hepatic failure in case transfused blood contain very low level (under the sensitivity of usual screening method) of hepatitis B virus (HBV). Redcross blood center and blood transfusion devision of our hospital have been employed reverse passive hemmaglutination method (RPHA) for HBsAg screening. Authors employed EIA for sensitive HBsAg test system and compared with RPHA method. Of 2,255 sera from blood bonors, 21 sera showed HBsAg by EIA. Of those 21 HBsAg sera, 4 were negative for HBsAg when tested by RPHA. So about 20% of HBsAg positive sera containing very low level HBV and RPHA could not detect them. For the prevention of post transfusion type B hepatitis, authors changed the HBsAg screening method to EIA. Relationship with so called non-A non-B hepatitis and anti-HCV was investigted. Anti-HCV was detected frequently in patients clinically diagnosed as non-A non-B hepatitis, and correlation of anti-HCV positivity and blood transfusion indicates the importance of the anti-HCV screening in blood transfusion.
新潟医学会
1990-12
jpn
departmental bulletin paper
http://hdl.handle.net/10191/35151
https://niigata-u.repo.nii.ac.jp/records/21731
AN00182415
00290440
新潟医学会雑誌
新潟医学会雑誌
104
12
992
998
https://niigata-u.repo.nii.ac.jp/record/21731/files/104(12)_992-998.pdf
application/pdf
2.0 MB
2019-08-16